BrightSpring Health Services Prices Secondary Stock Offering and Plans Concurrent Repurchase

LOUISVILLE, Ky., March 2, 2026 – BrightSpring Health Services, Inc. (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced the pricing of its previously announced underwritten secondary offering of common stock by certain existing shareholders, along with a plan for a concurrent repurchase of a portion of those shares.

Details of the Secondary Offering

The offering has been priced at $41.15 per share for a total of 20,000,000 shares of common stock, with all proceeds from the sale going directly to the selling stockholders. No new shares are being issued by BrightSpring itself in this offering, meaning the company will not receive any of the proceeds from the sale. This type of transaction is known as a secondary offering, where current investors sell their shares to new buyers in the market.

The selling stockholders include an affiliate of Kohlberg Kravis Roberts & Co. L.P. (KKR) as well as certain members of BrightSpring’s management team. The underwritten offering is expected to close on or about March 4, 2026, subject to customary closing conditions.

Concurrent Share Repurchase Program

Alongside the secondary offering, BrightSpring has authorized a concurrent share repurchase program, under which the company intends to repurchase up to 1,464,807 shares of its common stock from the underwriter at the same price paid by the public in the offering, or $41.15 per share. The underwriter will not earn any underwriting fees on the shares that the company repurchases.

This repurchase is subject to the successful closing of the offering and is expected to occur at the same time that the offering closes. While the share repurchase is contingent on the offering’s completion, the offering itself is not dependent on whether the repurchase proceeds.

Underwriters and Legal Framework

Goldman Sachs & Co. LLC is serving as the sole book-running manager for the offering. The shares were registered on a shelf registration statement on Form S-3, which was filed with the U.S. Securities and Exchange Commission (SEC) and automatically became effective when filed. This press release does not constitute an offer to sell or a solicitation of an offer to buy the shares in any jurisdiction where such offers would be unlawful.

The registration and sale of the shares will be made exclusively through a prospectus supplement and accompanying prospectus, copies of which may be obtained through Goldman Sachs & Co. LLC’s Prospectus Department by contacting them directly.

Forward-Looking Statements

The announcement includes forward-looking statements about future events and expectations. These statements are based on BrightSpring’s current expectations and are not guarantees of future performance. They are subject to risks and uncertainties that could cause actual outcomes to differ materially from expectations, including changes in economic conditions, competitive environments, regulatory requirements, or other risk factors discussed in the company’s SEC filings.

Market and Strategic Context

The secondary offering and repurchase plan come at a time when BrightSpring has been actively managing its capital structure and providing liquidity options to existing shareholders. Secondary offerings do not directly raise capital for the company, but they do support trading liquidity and can help diversify the shareholder base. Concurrent share repurchases can signal confidence in the company’s valuation and may support the stock’s trading price by reducing available shares in the market.

About BrightSpring Health Services

BrightSpring Health Services, Inc. is a national provider of healthcare services that specializes in delivering home and community-based care, including pharmacy solutions, clinical services, and behavioral health services to patients with complex needs across the United States. Its services are primarily focused on populations that benefit from support outside traditional inpatient settings. The company operates under the NASDAQ ticker BTSG.

Expected Timeline and Investor Impact

The offering is expected to close on March 4, 2026, with the concurrent purchase of shares occurring simultaneously. Investors closely watching the transaction will likely focus on trading volumes, equity float changes, and the potential market signal sent by the company’s willingness to repurchase part of the shares. While the company does not receive direct proceeds from the secondary sale, the repurchase could support shareholder value by indicating confidence in long-term prospects.

#BrightSpring #SecondaryOffering #ShareRepurchase #BTSG #SlimScan #GrowthStocks #CANSLIM